Coinduction (anaesthetics)
Coinduction (anaesthetics) is a term used in the field of anaesthesiology to describe the process of using multiple anaesthetic agents to induce anaesthesia. This technique is often employed to take advantage of the synergistic effects of different anaesthetic agents, thereby reducing the dose of each individual agent and potentially minimizing their side effects.
History[edit | edit source]
The concept of coinduction was first introduced in the mid-20th century, as anaesthesiologists began to explore the benefits of using multiple anaesthetic agents. This was a significant departure from the traditional approach of using a single agent, and it has since become a standard practice in many clinical settings.
Technique[edit | edit source]
Coinduction typically involves the use of two or more anaesthetic agents, each with different pharmacological properties. The choice of agents depends on a variety of factors, including the patient's medical history, the nature of the procedure, and the anaesthesiologist's personal preference.
Commonly used agents for coinduction include propofol, midazolam, and fentanyl. These agents are often administered in a sequential manner, with the aim of achieving a smooth and rapid induction of anaesthesia.
Advantages[edit | edit source]
The primary advantage of coinduction is that it allows for a reduction in the dose of each individual anaesthetic agent. This can help to minimize the risk of side effects, such as respiratory depression, hypotension, and postoperative nausea and vomiting.
In addition, the use of multiple agents can provide a more balanced anaesthetic effect, with improved analgesia and amnesia.
Disadvantages[edit | edit source]
Despite its advantages, coinduction is not without its drawbacks. The use of multiple agents can increase the complexity of the anaesthetic procedure, and it requires a thorough understanding of the pharmacology of each agent.
Furthermore, the synergistic effects of the agents can be unpredictable, and there is a risk of drug interactions.
See also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
